CASTLE BIOSCIENCES, INC. (CSTL) Net margin 2018–2025
CASTLE BIOSCIENCES, INC. (CSTL) net profit margin by fiscal year — reported net income divided by reported revenue.
-7.0%FY2025 · since FY2018: -27.9% → -7.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -7.0% | -12.5 pp |
| FY2024 | 5.5% | +31.6 pp |
| FY2023 | -26.1% | +22.8 pp |
| FY2022 | -49.0% | -15.7 pp |
| FY2021 | -33.3% | -16.8 pp |
| FY2020 | -16.4% | -26.6 pp |
| FY2019 | 10.2% | +38.1 pp |
| FY2018 | -27.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More CSTL financial trends
CSTL RevenueCSTL Net incomeCSTL Gross profitCSTL Gross marginCSTL Operating incomeCSTL Operating marginCSTL Operating cash flowCSTL Free cash flowCSTL Capital expendituresCSTL Return on equityCSTL Stock buybacksCSTL Dividends paidCSTL Total assetsCSTL Total liabilitiesCSTL Shareholders’ equityCSTL overview →